Rodrigues, Ana PaulaMachado, AusendaNunes, BaltazarGonçalves, PauloSimões, Maria João2015-09-172015-09-172015-09-09http://hdl.handle.net/10400.18/3117PneumoPAC 1. Descriptive study 2. Primary Objective To estimate the etiological fraction of Streptococcus pneumoniae CAP and CAP caused by PCV13 serotypes within all CAP cases a>ended in primary health care (Portugal, 2016) 3. Secondary Objective To evaluate the feasibility of conducting a study of vaccine effectiveness against CAP caused by PCV13 serotypes a>ended in primary care seGng using an indirect cohort design 4. Study population Community-dwelling individuals with 65 or more years of age in the catchment area of the participating GP 5. Outcomes of interest Streptoccocus pneumoniae CAP, PCV13 serotypes CAPengPneumonia Adquirida na ComunidadeIdososVacina AntipneumocócicaEfectividadeDeterminantes da Saúde e da DoençaInfecções Respiratóriasconference object